Stage 2 Trial Of Oxford COVID-19 Vaccine Candidate To Begin Today

Stage 2 of human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to start today.

The observer-blind, randomised controlled study to determine the safety and immunogenicity of “Covishield” on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.

Serum Institute of India has inked with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.

Suriya to donate Rs 5 crores for COVID 19 relief work

“We have got all approvals from the Central Drugs Standard Control Organisation (CDSCO). We are going to start the human clinical trial process at the Bharati Vidyapeeth (Deemed to be University) Medical College and Hospital from August 25. We are sure that in line with the philosophy of our group, we are going to make available a world class COVID-19 vaccine for people of our country and make our country ‘AatmaNirbhar’,” Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs, Serum Institute of India (SII) said.